HDFC Ergo sees capital infusion of 80 cr in near future

HDFC Ergo sees capital infusion of 80 cr in near future

“We may need a capital infusion of around 25-30 crore in the current fiscal as around 75 crore has already been infused into the insurance firm. Similarly, we will require around 50 crore in the next fiscal," HDFC Ergo General Insurance chief executive Officer Ritesh Kumar told PTI here.

Promoters of the general insurance firm, namely premier mortgage lender HDFC and Germany’s Ergo International, have already pumped in around 75 crore in the first half of this financial year. The firm has an equity capital base of 500 crore as of now, he said.

Kumar, however, pointed out that the company would not require huge capital from the promoters in future as it has turned profitable on entity level from the last quarter.

“We don’t need large support from the promoters as the growth can be funded from internal accruals," he added.

HDFC Ergo posted net profit at 14 crore in the April-June quarter and is expecting to retain profit for the whole fiscal. “We hope that profitability will be sustained in the rest half of the year," Kumar said.

On the premium front, the general insurance firm has set a target of 35-40% premium growth for this fiscal.

“We had a premium collection of 1,300 crore in the last fiscal and we aim to have 35-40 per cent growth in premium in the current fiscal," Kumar said, adding the insurer has witnessed 44 per cent growth in premium collection in H1 of FY12.

HDFC Ergo draws around one third of its revenue from accident and health insurance segments, one third from motor insurance and rest from corporates.

“Growth in all segments is good. However, there are issues relating to third party motor pool, which is a concern for all general life insurance companies in the country," Kumar added.